Coordinating emergent procedures after andexanet alfa

MeSH terms

• Antidotes / administration & dosage
• Antidotes / pharmacokinetics
• Antidotes / therapeutic use*
• Blood Coagulation Factors / therapeutic use
• Blood Component Transfusion
• Blood Loss, Surgical
• Cerebral Hemorrhage / drug therapy
• Drug Administration Schedule
• Emergencies*
• Factor Xa / administration & dosage
• Factor Xa / pharmacokinetics
• Factor Xa / therapeutic use*
• Factor Xa Inhibitors / adverse effects*
• Hemorrhage / chemically induced
• Hemorrhage / drug therapy*
• Hemorrhage / etiology
• Hemorrhage / therapy
• Humans
• Intraoperative Care
• Premedication*
• Preoperative Care
• Pyrazoles / adverse effects
• Pyrazoles / antagonists & inhibitors
• Pyrazoles / therapeutic use
• Pyridones / adverse effects
• Pyridones / antagonists & inhibitors
• Pyridones / therapeutic use
• Recombinant Proteins / administration & dosage
• Recombinant Proteins / pharmacokinetics
• Recombinant Proteins / therapeutic use*
• Rivaroxaban / adverse effects
• Rivaroxaban / antagonists & inhibitors
• Rivaroxaban / therapeutic use
• Wounds and Injuries / complications